OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
The OncLive Insider app is live!CME Opportunities
Specialty
View MoreBreast CancerLung CancerGastrointestinal CancerGenitourinary CancersOvarian CancerProstate CancerMelanoma & Skin CancerMCLMPNCAR T-cell TherapyChronic Lymphocytic LeukemiaGynecologic OncologyHematologic OncologyImmuno-OncologyMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
PartnersPublications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker ConsortiumSubscribe
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2025 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • The OncLive Insider app is live!
  • CME Opportunities
SpecialtySee All >
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Ovarian Cancer
  • Prostate Cancer
  • Melanoma & Skin Cancer
  • MCL
  • MPN
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gynecologic Oncology
  • Hematologic Oncology
  • Immuno-Oncology
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Update on Advanced Breast Cancer Treatment

EP. 1: Treating Intermediate Risk Individuals with Breast Cancer

February 2nd 2016

EP. 2: Genomic Testing in Breast Cancer

February 2nd 2016

EP. 3: Managing Luminal A and Luminal B Breast Cancer

February 2nd 2016

EP. 4: Appropriate Duration of Endocrine Therapy in Breast Cancer

February 2nd 2016

EP. 5: The Role of Fulvestrant in Metastatic HR+ Breast Cancer

February 2nd 2016

EP. 6: Review of Clinical Data on Palbociclib in Breast Cancer

February 2nd 2016

EP. 7: Managing Mouth Sores in Patients with Breast Cancer

February 2nd 2016

EP. 8: First-Line Treatment of HER2-Positive MBC

February 2nd 2016

EP. 9: MARIANNE and BOLERO-1 Trial Results in Breast Cancer

February 2nd 2016

EP. 10: Neoadjuvant Therapy for HER2+ Breast Cancer

February 2nd 2016

EP. 11: Post-Adjuvant Breast Cancer Treatment

February 2nd 2016

EP. 12: Neoadjuvant Treatment in Triple-Negative Breast Cancer

February 2nd 2016

EP. 13: Analyzing the Use of Eribulin in Metastatic Breast Cancer

February 2nd 2016

EP. 14: Immunotherapy in Breast Cancer

February 2nd 2016

EP. 15: Prospects in the Management of Breast Cancer

February 2nd 2016